公共头尾

  1. Home
  2. Click Chemistry
  3. Cells and Genes

Featuring talks by

Prof. WU Mingxuan

Assistant professor, Westlake University

Topic: Development of New Sortase-Mediated Methods for Investigation of Histone Modifications

Prof. Katsunori TANAKA

Professor, School of Materials and Chemical Technology, Tokyo Institute of Technology; Chief Scientist, Biofunctional Synthetic Chemistry Laboratory, RIKEN

Topic: Therapeutic in Vivo Synthetic Chemistry

Prof. GAO Bing

Professor, School of Chemistry and Chemical Engineering, Hunan University

Topic: S(VI)-C Ligation Through Radical and Enantioselective Reactions

Moderated by

Prof. DONG Jiajia

Professor, Institute of Translational Medicine, Shanghai Jiao Tong University; Distinguished Professor, WLA Labs

Topic: The FSO2N3, an Unexpected Journey

About the Session

New Chemistry And Tools

About the Speeches

WU Mingxuan
Assistant Professor, Department of Chemistry, Westlake University

Brief bio: Mingxuan obtained his B.S. and M.S. degrees from the School of Life Science and Biotechnology at Shanghai Jiao Tong University. He received his Ph.D. degree in chemistry from Princeton University under the supervision of Dorothea Fiedler. Next, he joined the Phil Cole lab for postdoc training at Johns Hopkins University School of Medicine and later moved to Harvard Medical School Brigham and Women's Hospital. He was appointed to the Department of Chemistry at Westlake University in 2019 as an Assistant Professor.

Topic: Development of New Sortase-Mediated Methods for Investigation of Histone Modifications


Abstract: Posttranslational modifications of histone H3 and H4 play significant roles in the regulation of epigenetic status. Chemical methods that precisely manipulate histone modifications are desired for basic research and therapeutic applications. Here we report two new sortase-mediated methods toward the goal. First, we developed a semisynthesis method of histone H4 via sortase mediated ligation. It allowed us to identify novel H4K20me3 readers by photo-crosslinking from multifunctional nucleosome probes. Second, we report a method to edit the N-tail of histone H3 via sortase mediated metathesis. Specific PTM patterns could be incorporated into histone H3 on nucleosomes in vitro and in cellulose. We expect the new tools could accelerate the understanding of histone modifications and have the potential for epigenome editing.

Katsunori TANAKA
Professor, School of Materials and Chemical Technology, Tokyo Institute of Technology; Chief Scientist, Biofunctional Synthetic Chemistry Laboratory, RIKEN

Brief bio: Katsunori Tanaka received his Ph.D. (2002) from Kwansei Gakuin University, Japan, under the direction of Prof. Shigeo Katsumura. After a post-doc with Prof. Koji Nakanishi at Columbia University (2002-2005), he joined Professor Koichi FUKASE's group at Osaka University as an Assistant Professor. He moved to RIKEN as an Associate Chief Scientist in 2012. He was then appointed as a Chief Scientist, at RIKEN Cluster for Pioneering Research in 2017 and as a Professor in the Department of Chemical Science and Engineering, Tokyo Institute of Technology (2019), under the cross-appointment system. He received several awards including Best Electric Guitar Player under 20 in Japan (1994), Young Scientist's Research Award in the 2nd Natural Product Chemistry Symposium (2002), Young Scientist's Research Award in the 46th Chemistry of National Products (2004), Young Investigator's Award in the 46th Japanese Society of Carbohydrate Research (2010), Incentive Award in The Society of Synthetic Organic Chemistry, Japan (2011), American Chemical Society (ACS) Division of Carbohydrate Chemistry, Horace S. Isbell Award (2015), JSPS Prize (2018), The Chemical Society of Japan (CSJ) Award for Creative Work (2019), Astellas Award for the Best Biomedical Research (2022), and Kaneka Life Science Industrial Award in The Society of Synthetic Organic Chemistry, Japan (2023).

Topic: Therapeutic in Vivo Synthetic Chemistry

Abstract: The long-term goal of our research is to develop the working tools and methodologies that will form the foundation of "Therapeutic in Vivo Synthetic Chemistry". The main benefit of this approach is that synthetic transformations can be directly performed at target regions within the body to generate molecules that elicit localized biological effects. This method should largely circumvent off-target binding and instability issues associated with current drug administration techniques. In these years, we have engaged this topic through two different approaches. The first is through the usage of glycosylated artificial metalloenzymes, where the primary aim is to exploit the chemoselectivity of embedded, non-natural transition metal catalysts for the synthesis/release of bioactive molecules. The second approach is rather centered on discovering chemical probes with novel and selective reactivity to biological metabolites naturally overexpressed in cancer cells. Once developed, the objective is then to adapt them for synthesizing diagnostic probes or anticancer drugs. Overall, we have been dedicated to developing the initial working proofs-of-concept and then to spearheading investigations towards their utility for therapeutic and diagnostic applications.

GAO Bing
Professor, School of Chemistry and Chemical Engineering, State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, Hunan University

Experience and Education:
GAO Bing earned his Ph.D. in 2014 from the Shanghai Institute of Organic Chemistry under the guidance of Professor HU Jinbo. His doctoral research primarily focused on the development of novel reagents and methodologies for integrating fluorine-containing modules into functional molecules. In early 2015, he commenced his post-doctoral fellowship at Scripps Research in San Diego, where he collaborated with Professor Karl Barry Sharpless in the field of sulfur fluoride exchange reactions. In 2019, he joined Hunan University as a joint professor in the Chemistry Department and the State Key Laboratory.

Topic: S(VI)-C Ligation Through Radical and Enantioselective Reactions

Abstract: Sulfur(VI) Fluoride Exchange (SuFEx) is the latest generation of Click reactions developed by Sharpless in the year of 2014. It highlights the unique properties of hypervalent sulfur(VI) fluoride compounds in connecting chemical fragments through fluoride exchange reactions. Linkages are created under stringent conditions through the nucleophilic substitution of fluoride by phenols, alcohols, and amines. In this presentation, GAO and coworkers are going to report a few novel ligation processes that allow for efficient connection of carbon nucleophiles.

DONG Jiajia
Professor, Institute of Translational Medicine, Shanghai Jiao Tong University; Distinguished Professor, WLA Labs

Brief bio: Dong Jiajia was born in China and received his B.A. from Xiamen University in 2000. Prof. Jiang Biao supervised his 2006 Ph.D. in organic chemistry from the Shanghai Institute of Organic Chemistry (SIOC). He was a senior scientific researcher at Egret Pharma, Shanghai, before becoming a postdoctoral associate in 2009-2015 with Prof. K. Barry Sharpless's group at The Scripps Research. During his postdoctoral work at Scripps Research, Jiajia discovered the 'Sulfur(VI) Fluoride Exchange (SuFEx) reaction' with Professor Sharpless. He is currently a professor at Shanghai Jiao Tong University. His research interests mainly focus on 'SuFEx click chemistry.'

Topic: The FSO2N3, an Unexpected Journey

Abstract: In 2018, our team discovered a mild and efficient process to prepare FSO2N3, then revealed the efficient diazo transfer process of FSO2N3. This discovery changed the scientific goal of our team. We realized we could construct a large-scale azide building blocks library through this new process. Then, we coupled the ligand-accelerated CuAAC reaction of any given terminal alkynes and our azides to rapidly generate a triazole library in a liquid phase at low concentration. Without separation and purification, we could use these modular click chemistry libraries to search for molecule functions. Especially a phenotypic screen for biological functions, a feat that previous combinatorial libraries could not achieve. In the past five years, we have been trying to push the number of azides to 5,000, and now we are aiming for 10,000.